1171399

Hikma Injectables USA Inc. — FEI 3022897129

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dayton, NJ (United States)

Citations

IDCFRDescription
143321 CFR 211.42(c)(10)(iii)Air Supply
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
192621 CFR 211.166(b)Adequate number of batches on stability